Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,000,002
-$2,610,501 QoQ
Shares Held
36,758
-65.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#267
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. EXEL ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
36,758 | $2,000,002 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,000,002 | 36,758 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,610,503 | 107,496 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,155,748 | 140,446 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $732,083 | 17,726 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $4,590,314 | 104,136 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,967,940 | 107,474 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,078,386 | 62,414 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $126,895 | 4,890 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $112,911 | 5,025 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,012,772 | 42,679 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $195,278 | 8,140 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $94,829 | 4,340 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $82,937 | 4,340 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $84,239 | 4,340 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $506,238 | 31,561 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $43,120 | 2,750 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $231,518 | 11,120 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $252,090 | 11,120 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $271,256 | 14,839 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $387,242 | 18,318 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $411,280 | 22,573 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $509,924 | 22,573 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $453,040 | 22,573 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $406,163 | 16,612 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $525,651 | 22,142 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $223,601 | 12,985 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||